P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines

Experimental Cell Research

Volumn 312, Issue 20, 2006, Pages 4070-4078

  Solazzo, Michela ^a   Fantappiè, Ornella ^a   Lasagna, Nadia ^a   Sassoli, Chiara ^b   Nosi, Daniele ^b   Mazzanti, Roberto ^a  

^a Medical Oncology Unit   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cancer; Mitochondria; Multidrug resistance; P gp; Rho 123

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; RHODAMINE 123; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL LINE; CONFOCAL LASER MICROSCOPY; CYTOSOL; DNA DAMAGE; DRUG SENSITIVITY; DRUG TRANSPORT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

EID: 33751520985     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.09.005     Document Type: Article

References (33)

1. Huesker M., Folmer Y., Schneider M., Fulda C., Blum H.E., and Hafkemeyer P. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes. Hepatology 36 (2002) 874-884
2. Wiese M., and Pajeva J.K. Structure-activity relationships of multidrug resistance reversers. Curr. Med. Chem. 8 (2001) 685-713
3. Kvackajova-Kisucka J., Barancik M., and Breier A. Drug transporters and their role in multidrug resistance of neoplastic cells. Gen. Physiol. Biophys. 20 (2001) 215-237
4. Gottesman M.M., and Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62 (1993) 385-427
5. Germann U.A. P-glycoprotein-A mediator of multidrug resistance in tumour cells. Eur. J. Cancer 32 (1996) 927-944
6. Mazzanti R., Croop J.M., Gatmaitan Z., Budding M., Steiglitz K., Arceci R., and Arias I.M. Benzquinamide inhibits P-glycoprotein mediated drug efflux and potentiates anticancer agent cytotoxicity in multidrug resistant cells. Oncol. Res. 8-9 (1992) 359-365
7. Breier A., Barancik M., Sulova Z., and Uhrik B. P-glycoprotein-Implications of metabolism of neoplastic cells and cancer therapy. Curr. Cancer Drug Targets 5 (2005) 457-468
8. Stride B.D., Cole S.P., and Deeley R.G. Localization of a substrate specificity domain in the multidrug resistance protein. J. Biol. Chem. 274 (1999) 22877-22883
9. Marquardt D., McCrone S., and Center M.S. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. Cancer Res. 50 (1990) 1426-1430
10. Shapiro A.B., Fox K., Lee P., Yang Y.D., and Ling V. Functional intracellular P-glycoprotein. Int. J. Cancer 76 (1998) 857-864
11. Van Luyn M.J., Muller M., Renes J., Meijer C., Scheper R.J., Nienhuis E.F., Mulder N.H., Jansen P.L., and De Vries E.G. Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1. Int. J. Cancer 76 (1998) 55-62
12. Meschini S., Calcabrini A., Monti E., Del Bufalo D., Stringaro A., Dolfini E., and Arancia G. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells. Int. J. Cancer 87 (2000) 615-628
13. Maraldi N.M., Zini N., Santi S., Scotlandi K., Serra M., and Baldini N. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Biol. Cell 91 (1999) 17-28
14. Willingham M.C., Richert N.D., Cornwell M.M., Tsuruo T., Hamada H., Gottesman M.M., and Pastan I.H. Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells. J. Histochem. Cytochem. 35 (1987) 1451-1456
15. Gong Y., Wang Y., Chen F., Han J., Miao J., Shao N., Fang Z., and Ou Yang R. Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line. Leuk. Res. 24 (2000) 769-774
16. Gervasoni Jr. J.E., Fields S.Z., Krishna S., Baker M.A., Rosado M., Thuraisamy K., Hindenburg A.A., and Taub R.N. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res. 51 (1991) 4955-4963
17. Rutherford A.V., and Willingham M.C. Ultrastructural localization of daunomycin in multidrug-resistant cultured cells with modulation of the multidrug transporter. J. Histochem. Cytochem. 41 (1993) 1573-1577
18. Molinari A., Cianfriglia M., Meschini S., Calcabrini A., and Arancia G. P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int. J. Cancer 59 (1994) 789-795
19. Lasagna N., Fantappie O., Solazzo M., Morbidelli L., Marchetti S., Cipriani G., Ziche M., and Mazzanti R. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res. 66 (2006) 2673-2682
20. Smyth M.J., Krasovskis E., Sutton V.R., and Johnstone R.W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7024-7029
21. Mantovani I., Cappellini A., Tazzari P.L., Papa V., Cocco L., and Martelli A.M. Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. J. Cell. Physiol. 207 (2006) 836-844
22. Macnab G.M., Alexander J.J., Lecatsas G., Bey E.M., and Urbanowicz J.M. Hepatitis B surface antigen produced by a human hepatoma cell line. Br. J. Cancer 34 (1976) 509-515
23. Mazzanti R., Gatmaitan Z., Croop J.M., Shu H., and Arias I.M. Quantitative image analysis of Rhodamine 123 transport by adriamycin-sensitive and resistant NIH 3T3 and human hepatocellular carcinoma (Alexander) cells. J. Cell. Pharmacol. 1 (1990) 50-56
24. Croop J.M., Guild B.C., Gros P., and Housman D.E. Genetics of multidrug resistance: relationship of a cloned gene to the complete multidrug resistant phenotype. Cancer Res. 47 (1987) 5982-5988
25. Neyfakh A.A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res. 174 (1988) 168-176
26. Johnson L.V., Walsh M.L., and Chen L.B. Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 990-994
27. Nare B., Prichard R.K., and Georges E. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Mol. Pharmacol. 45 (1994) 1145-1152
28. Kim M., Cooper D.D., Hayes S.F., and Spangrude G.J. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 91 (1998) 4106-4117
29. Gupta S., and Knowlton A.A. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 106 (2002) 2727-2733
30. Mazzanti R., Fantappie O., Fabrizio P., and Relli P. Susceptibility to lipid peroxidation of human hepatocellular carcinoma cell lines with different levels of multiple drug-resistant phenotype. Lab. Invest. 73 (1995) 419-423
31. Fantappie O., Lodovici M., Fabrizio P., Marchetti S., Fabbroni V., Solazzo M., Lasagna N., Pantaleo P., and Mazzanti R. Vitamin E protects DNA from oxidative damage in human hepatocellular carcinoma cell lines. Free Radical Res. 38 (2004) 751-759
32. Kojima H., Endo K., Moriyama H., Tanaka Y., Alnemri E.S., Slapak C.A., Teicher B., Kufe D., and Datta R. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J. Biol. Chem. 273 (1998) 16647-16650
33. Munteanu E., Verdier M., Grandjean-Forestier F., Stenger C., Jayat-Vignoles C., Huet S., Robert J., and Ratinaud M.H. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells. Biochem. Pharmacol. 71 (2006) 1162-1174